Scope of the Report
The report provides Segmentation by Drug Class
• Endothelin receptor antagonists
• Prostacyclin and Prostacyclin Analogs
• Phosphodiesterase V Inhibitors
• Others

The report provides coverage by Region
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa (MEA)

The report provides coverage by Country
• USA
• Canada
• UK
• Germany
•Japan
• Brazil
• South Africa
List of Figure
Figure 1: Global PAH Market, 2011-2015 (USD Billion)
Figure 2: Types of pulmonary arterial hypertension
Figure 3: PAH Associated With Other Diseases (APAH)
Figure 4: Global PAH Market, 2016E-2021F (USD Billion)
Figure 5: Global PAH Market: By Drug Class Type, By Value, 2016E (In Percentage)
Figure 6: Global PAH Market: By Drug Class Type, By Value, 2021F (In Percentage)
Figure 7: Global PAH Market: By ERA, By Value, 2011-2021F (in USD Billion)
Figure 8: Global PAH Market: By Prostacyclin and Prostacyclin Analogs, By Value, 2011-2021F (in USD Billion)
Figure 9: Global PAH Market: By Phosphodiesterase V Inhibitors, By Value, 2011-2021F (in USD Million)
Figure 10: Global PAH Market: By Others, By Value, 2011-2021F (in USD Million)
Figure 11: North America PAH Market, 2011-2015 (USD Billion)
Figure 12: North America PAH Market, 2016E- 2021F (USD Billion)
Figure 13: USA PAH Market Size, By Value, 2011-2021F (in USD Billion)
Figure 14: Estimated Number of Cases of PAH in USA
Figure 15: Canada PAH Market Size, By Value, 2011-2021F (in USD Million)
Figure 16: Estimated Number of Cases of PAH in Canada
Figure 17: Europe PAH Market, 2011-2015 (USD Billion)
Figure 18: Europe PAH Market, 2016E- 2021F (USD Billion)
Figure 19: UK PAH Market Size, By Value, 2011-2021F (in USD Million)
Figure 20: Germany PAH Market Size, By Value, 2011-2021F (in USD Million)
Figure 21: Estimated Number of Cases of PAH in Germany
Figure 22: APAC PAH Market, 2011-2015 (USD Million)
Figure 23: APAC PAH Market, 2016E - 2021F (USD Million)
Figure 24: Japan PAH Market Size, By Value, 2011-2021F (in USD Million)
Figure 25: Estimated Number of Cases of PAH in Japan
Figure 26: Latin America PAH Market, 2011-2015 (USD Million)
Figure 27: Latin America PAH Market, 2016E- 2021F (USD Million)
Figure 28: Brazil PAH Market Size, By Value, 2011-2021F (in USD Million)
Figure 29: Estimated Number of Cases of PAH in Brazil
Figure 30: MEA PAH Market, 2011-2015 (USD Million)
Figure 31: MEA PAH Market, 2016E- 2021F (USD Million)
Figure 32: South Africa PAH Market Size, By Value, 2011-2021F (in USD Million)
Figure 33: Estimated Number of Cases of PAH in South Africa
Figure 34: Global PAH Landscape – Market Share (2015)

List of Tables
Table 1: Prostacylin – Pipeline Drugs
Table 2: ERA – Pipeline Drugs
Table 3: PDA 5 Inhibitor – Pipeline Drugs
Table 4: PAH – Pipeline Drugs (Phase I & II)
Table 5: PAH – Pipeline Drugs (Phase III)
Table 6: Mergers and Acquisitions in PAH Market
Table 7: Licensing Agreements in PAH Market
Table 8: PAH Competitive Landscape: Product Benchmarking
Table 9: Actelion –Sales: 2013-2015
Table 10: United Therapeutics –Sales: 2013-2015
Table 11: Gilead Sciences –Sales: 2013-2015
Table 12: Pfizer-Revatio –Sales: 2013-2015
Link
http://www.azothanalytics.com/report/healthcare-pharma/global-pulmonary-arterial-hypertension-pah-market-by-drug-class-by-region-by-country-opportunities-and-forecasts-2016-2021-r58